-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED starts China Phase 3 trial of HMPL-760 plus R-GemOx in relapsed or refractory DLBCL

路透·03/23/2026 00:01:23

登录查看新闻详情